Stock research
LENZ LENZ Therapeutics, Inc.
Healthcare • Biotechnology
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's...…
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California.
ALL change
-94.63%
Range high
$106.34
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in LENZ?
Price
Showing ALL history. Source: FMP historical price full.
- Prev Close
- $5.05
- Day High
- $5.45
- Day Low
- $5.03
- 52w High
- $50.40
- 52w Low
- $4.68
- Volume
- 961,381
- Avg Volume
- Beta
- 1.621
* TTM/most recent where available
Company
- Ticker
- LENZ
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Evert Schimmelpennink
- Employees
- 152
- Website
- www.lenz-tx.com
Key Metrics
- Market Cap
- 165M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).